Addex Therapeutics (ADXN) EBIT (2017 - 2026)
Addex Therapeutics' (ADXN) quarterly EBIT came in at -$612741.3 in Q1 2026, up 9.13% year-over-year from -$561471.5 in Q1 2025, and up 37.15% quarter-over-quarter from -$974990.3 in Q4 2025.
Powered by 
Analysis
Addex Therapeutics (ADXN) EBIT (2017 - 2026) Analysis & Trends
Addex Therapeutics has disclosed EBIT across 10 years of filings, most recently posting -$612741.3 for Q1 2026.
- In Q1 2026, EBIT rose 9.13% year-over-year to -$612741.3; the TTM figure through Mar 2026 stood at -$3.3 million (up 39.56% YoY), while the FY2025 annual figure was -$3.4 million, down 8.39% from the prior year.
- EBIT came in at -$612741.3 for Q1 2026 at Addex Therapeutics, up from -$974990.3 in the prior quarter.
- In the past five years, EBIT ranged from a high of -$397867.8 in Q1 2023 to a low of -$21.3 million in Q4 2022.
- Average EBIT over 5 years is -$3.1 million, with a median of -$902797.7 recorded in 2024.
- Year-over-year, EBIT surged 94.02% in 2023 and slumped 126.91% in 2024.
- Over 5 years, EBIT stood at -$21.3 million in 2022, then surged by 88.13% to -$2.5 million in 2023, then decreased by 24.37% to -$3.1 million in 2024, then soared by 69.0% to -$974990.3 in 2025, then jumped by 37.15% to -$612741.3 in 2026.
- Per Business Quant data, the three most recent EBIT figures were -$612741.3 in Q1 2026, -$974990.3 in Q4 2025, and -$870295.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 4.27 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | 1.22 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | -505.13 Mn |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 697.90 Mn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 330.80 Mn |
| 10 | Addex Therapeutics | 6.46 Mn | 6.46 Mn | - | -612,741.33 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -612,741.33 |
| Dec 31, 2025 | -974,990.33 |
| Sep 30, 2025 | -870,294.99 |
| Jun 30, 2025 | -885,260.33 |
| Mar 31, 2025 | -674,315.23 |
| Dec 31, 2024 | -3.14 Mn |
| Sep 30, 2024 | -718,146.59 |
| Jun 30, 2024 | -994,457.78 |
| Mar 31, 2024 | -902,797.66 |
| Dec 31, 2023 | -2.53 Mn |
| Sep 30, 2023 | -848,251.72 |
| Jun 30, 2023 | -440,623.93 |
| Mar 31, 2023 | -397,867.83 |
| Dec 31, 2022 | -21.30 Mn |
| Sep 30, 2022 | -4.31 Mn |
| Jun 30, 2022 | -7.36 Mn |
| Mar 31, 2022 | -6.24 Mn |
| Dec 31, 2021 | -16.82 Mn |
| Sep 30, 2021 | -3.89 Mn |
| Jun 30, 2021 | -4.94 Mn |